Symrise's half-year sales rise on fragrance business growth
H1 sales rise 6.3% year-on-year to 2.57 billion euros
H1 EBITDA rises 11.5% to 529.8 million euros
Sees 2024 organic growth at upper end of 5-7% guidance
Adds CFO quote in paragraphs 5-6, share reaction in paragraph 8, analyst comments paragraph 9, division detail paragraph 11
By Antonis Pothitos
Aug 1 (Reuters) -German flavour and fragrance maker Symrise SY1G.DE posted a 6.3% rise in its half-year sales on Thursday, in line with expectations, mainly driven by its scent and care business.
Its revenue rose to 2.57 billion euros ($2.78 billion) in the January-June period, while analysts polled by Vara Research were expecting 2.56 billion euros on average.
Organic sales, which do not take currency exchange effects into account, increased by 11.5% in the same period.
Symrise, whose fragrances go into the perfumes of French luxury giants LVMH LVMH.PA and Kering PRTP.PA, confirmed its annual targets for organic sales growth of 5-7% and a core profit (EBITDA) margin of around 20%.
Finance chief Olaf Klinger said during a press conference that Symrise expected the organic growth to come at the upper end of that range at the minimum.
"We'll see if we can adjust it again at the end of Q3," he added.
Easing destocking trends are supporting flavour and fragrance makers' return to stable volumes, after a wave of inventory reductions and lower demand weighed on volumes throughout last year.
However, the company's shares slid 1.8% by 1130 GMT.
Baader Helvea analysts said the market had been looking for a slight beat to the consensus, while Morgan Stanley pointed to the lack of an upgrade in the margin guidance.
Half-year sales in Symrise's scent and care division rose 12.1% in the reporting currency, boosted by double-digit percent organic growth at its fine fragrances and consumer fragrances units.
The taste, nutrition and health segment, which makes ingredients used in food, beverages and pet food, posted a 2.9% revenue rise on the same basis.
Swiss rival Givaudan GIVN.S also posted higher half-year sales last week, although its second-quarter growth showed signs of stabilisation after a strong start to the year, sending its shares lower.
($1 = 0.9236 euros)
Reporting by Antonis Pothitos in Gdansk; Editing by Milla Nissi
Related Assets
Latest News
Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.
All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.
Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.
